Concord Wealth Partners - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 214 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.82 and the average weighting 0.0%.

Quarter-by-quarter ownership
Concord Wealth Partners ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$1,000
-50.0%
146
-54.1%
0.00%
Q4 2021$2,000
+100.0%
318
+189.1%
0.00%
Q3 2021$1,000
-66.7%
110
-69.9%
0.00%
-100.0%
Q2 2021$3,000
+200.0%
365
+251.0%
0.00%
Q1 2021$1,0001040.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Affinity Asset Advisors, LLC 200,000$998,0000.36%
Green Alpha Advisors, LLC 72,647$363,0000.24%
Skaana Management L.P. 227,851$1,137,0000.18%
SEVEN EIGHT CAPITAL, LP 196,351$980,0000.18%
Defender Capital, LLC. 103,038$514,0000.16%
Skaana Management L.P. 206,300$1,029,0000.16%
WASATCH ADVISORS LP 4,926,125$24,581,0000.10%
Parametrica Management Ltd 16,183$81,0000.08%
Cedar Brook Financial Partners, LLC 54,500$272,0000.07%
Hennion & Walsh Asset Management, Inc. 274,703$1,371,0000.07%
View complete list of INOVIO PHARMACEUTICALS INC shareholders